Q3 FY2026 · ended Sep 30, 2026 · Revenue $73.68B, +5.6% YoY · Filed Nov 5, 2026
The Cigna Group (CI) files with the SEC under industry code 6324, Hospital & Medical Service Plans. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $73.7 billion and net income of $1.4 billion. As of Sep 30, 2026 it held $26.3 billion in cash and investments and $500.0 million in total debt.
Revenue
$73.68B
+5.6% vs year-ago quarter
Net income
$1.44B
-13.1% vs prior quarter
Operating cash flow
$2.57B
-24.8% vs year-ago quarter
Free cash flow
—
EPS
$5.47
-21.6% vs year-ago quarter
Dividend per share
$1.56
+3.3% vs year-ago quarter
Shares outstanding
263.50M
-1.4% vs year-ago quarter
Net cash
$25.84B
Q3 FY2026
Operating margin
3.4%
TTM
Company profile
- Industry
- Hospital & Medical Service Plans (SIC 6324)
- Listed as
- CI (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bloomfield, CT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1739940
- Former names
- Cigna Corp (until Feb 9, 2023); Halfmoon Parent, Inc. (until Dec 20, 2018)
Other Hospital & Medical Service Plans companies
- Unitedhealth Group Inc UNH
- Elevance Health, Inc. ELV
- Humana Inc HUM
- Centene Corp CNC
- Molina Healthcare, Inc. MOH
- Oscar Health, Inc. OSCR
- Clover Health Investments, Corp. /DE CLOV
- Alignment Healthcare, Inc. ALHC
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $73.7B | $71.7B | $68.5B | $72.5B | $69.7B |
| Operating income | $2.4B | $2.7B | $2.4B | $2.3B | $2.6B |
| Net income | $1.4B | $1.7B | $1.7B | — | — |
| Diluted EPS | $5.47 | $6.29 | $6.26 | — | $6.98 |
| Operating cash flow | $2.6B | -$421.0M | $1.1B | $6.1B | $3.4B |
| Total assets | $157.6B | $157.1B | $153.3B | $157.9B | $157.9B |
| Total liabilities | $113.9B | $114.2B | $110.8B | $116.0B | $115.9B |
| Stockholders' equity | $43.4B | $42.6B | $42.2B | $41.7B | $41.8B |
| Cash and investments | $26.3B | $26.3B | $26.8B | $27.2B | $25.4B |
| Total debt | $500.0M | $1.0B | $29.4B | $111.0M | $30.9B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
All 1002 The Cigna Group SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.